A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease
Nature Medicine2017Vol. 23(8), pp. 945–953
Citations Over TimeTop 1% of 2017 papers
Salim S. Hayek, Kwi Hye Koh, Morgan E. Grams, Changli Wei, Yi‐An Ko, Jing Li, Beata Samelko, Hyun Lee, Ranadheer R. Dande, Ha Won Lee, Eunsil Hahm, Vasil Peev, Melissa Tracy, Nicholas J. Tardi, Vineet Gupta, Mehmet M. Altintas, Garrett Garborcauskas, Nikolina Stojanović, Cheryl A. Winkler, Michael S. Lipkowitz, Adrienne Tin, Lesley A. Inker, Andrew S. Levey, Martin Zeier, Barry I. Freedman, Jeffrey B. Kopp, Karl Skorecki, Josef Coresh, Arshed A. Quyyumi, Sanja Sever, Jochen Reiser
Related Papers
- ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients.(1997)
- → ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients(1997)127 cited
- → Neutrophils are a main source of circulating suPAR predicting outcome in critical illness(2019)58 cited
- → The urokinase receptor is overexpressed in the AIDs dementia complex and other neurological manifestations(2004)45 cited
- → Reduced Release of Intact and Cleaved Urokinase Receptor in Stimulated Whole‐Blood Cultures from Human Immunodeficiency Virus‐1‐Infected Patients(2005)9 cited